$70.03
+2.28 (+3.37%)
AXTI News10 articles
AXTI Surges 9.7% to $61.64, Yet Valuation Hits 21x Sales
AXT Inc. (AXTI) shares surged 9.7% to $61.64, valuing the company at $4.04 billion, or 21.2x annualized Q2 sales. But 42.5% of net income came from interest, not operations.
AXT Soars 27% on Record InP Sales and Margin Surge
AXT (NASDAQ:AXTI) shares surged 27% in premarket trading after the company reported record indium phosphide sales, driving gross margin to 44.9% and Q3 guidance well above consensus.
AXT Soars on AI Wafer Demand, Strong Margins and Guidance
AXT stock jumped 57% after a Q2 beat and strong Q3 guidance, fueled by AI-driven demand for indium-phosphide wafers and robust margin expansion.
AXTI Surges on Indium Phosphide Supply Constraints for AI Data Centers
AXTI surged 10.01% to $97.18 Friday and was indicated at $110.41 premarket Monday, driven by indium phosphide supply constraints for AI data centers. The stock now trades near or above analyst targets.
AXT Shares Surge to All-Time High on AI Data Center Demand
AXT shares closed at a record $140.83 on Friday, gaining 16.37% for the day and 13.8% for the week, fueled by demand for indium phosphide in AI data centers.
AXT Shares Surge to Record High on AI Optical Networking Demand
AXT shares surged 16.37% to $140.83, hitting a 52-week high, driven by AI optical networking demand and a $100M InP backlog.
AXT Reschedules Annual Meeting After Quorum Failure
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized shares.
AXT Raises $632.5M to Expand InP Wafer Production in China Amid AI Boom
AXT raised $632.5 million to boost indium phosphide wafer production in China, betting on AI demand. First-quarter revenue is projected at $26-$28 million, with a net loss up to $2.6 million.
AXT Shares Retreat on Insider Sale Plans Following Sector Rally
AXT Inc shares declined over 6% in premarket trading Tuesday, giving back part of Monday's 22% surge. SEC filings revealed the CEO, CFO, and a director filed to sell a combined 753,801 shares worth approximately $30.2 million.
Baxter Shares Rise on Q1 Beat; Novum Pump Issues Loom Over 2026 Outlook
Baxter topped Q1 earnings expectations, sending shares up 4%, but the company's 2026 outlook remains unchanged amid ongoing Novum pump challenges and tariff pressures.